Review Article
Volume 19 Issue 6 - 2020
Covid-19 Public Health Emergency: Mini Review and Impact on Maxillofacial Practice in Serbia- What we have Learnt during Our Wireless Journal Club between 10th and 30th March
Melvil Šabani, Drago Jelovac*, Danilo Nikolić, Ana Durković, Aleksandar Stefanović, Milan Petrović and Vitomir Konstantinović
Clinic for Maxillofacial Surgery, School of Dental Medicine, University of Belgrade, Serbia
*Corresponding Author: Drago Jelovac, Clinic for Maxillofacial Surgery, School of Dental Medicine, University of Belgrade, Serbia.
Received: April 09, 2020; Published: May 16, 2020




Abstract

From the global outbreak of SARSCoV-2 caused infection disease in 2019, the state of emergency was declared on the territory of the republic of Serbia with serious consequences on the entire population and the National Health Service. The mini review and the description of the reorganization of the Clinic for maxillofacial surgery School of Dental Medicine, University of Belgrade, provided in this paper is not a recommendation but a background to help practitioners to better understand this novel coronavirus pandemic and its impact on maxillofacial practice in Serbia during challenging conditions.

Keywords: Covid-19; Maxillofacial Practice; Serbia

References

  1. Službeni glasnik RS, number 15/16.
  2. Coronavirus disease (COVID-19) Pandemic.
  3. https://covid19.rs/
  4. Gui-Qiang Wang. “Department of Infectious Diseases Peking University First Hospital: Diagnosis and treatment protocol of Covid-19 (trial version 7) released by National Health Commission and State Administration of Traditional Chinese Medicine (2020).
  5. Linee Guida Cinesi sulla Gestione di Covid-19 Versione 7°, Publicate in data 3/3/2020 dalla Comimissione della Salute Nazionale della R.P.C e dall ‘ Administrazione Nazionale della Medicina tradizionale della R.P.C, tradotto da Jinwei Sun.
  6. Zhou F., et al. “Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: a retrospective cohort study”. Lancet 395.10229 (2020): 1054-1062. 
  7. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Chinese Center for Disease Control and Prevention, Beijing 102206, China. “The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China”. CCDC Weekly 2.8 (2020).
  8. Battegay M., et al. “2019- Novel Coronavirus (2019-nCoV); estimating the case fatality rate-a word of caution”. Swiss Medical Weekly (2020). 
  9. Verity R., et al. “Estimates of the severity of coronavirus disease 2019: a model-based analysis”. The Lancet Infectious Diseases (2020): 30243-30247. 
  10. Hoffmann M., et al. “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor”. Cell 20 (2020): 30229-30224. 
  11. Fang L., et al. “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?” Lancet Respiratory Medicine 8.4 (2020): e21. 
  12. Fang L., et al. “Antihypertensive drugs and risk of COVID-19? - Authors' reply”. Lancet Respiratory Medicine 8.5 (2020): e32-e33. 
  13. Thevarajan I., et al. “Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19”. Nature Medicine (2020).
  14. Guo Y., et al. “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status”. Military Med Res 7.11 (2020). 
  15. Felice Galluccio and Mario Fajardo. “Hyperimmune serum transfusions (convalescent patients)”. LMWH. Therapeutic Algorithm for COVID-19. Rheuma pain workshop.
  16. Lechien JR., et al. “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study”. European Archives of Oto-Rhino-Laryngology (2020). 
  17. Prise d'anti-inflammatoires et COVID-19.
  18. https://uitspraken.rechtspraak.nl/inziendocument?id=ECLI:NL:RBNHO:2013:8527
  19. Herfst S., et al. “Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets”. Science 336.6088 (2012): 1534-1541. 
  20. Russell CA., et al. “The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host”. Science 336.6088 (2012): 1541-1547. 
  21. Wain-Hobson S. “The Irrationality of GOF Avian Influenza Virus Research”. Frontiers in Public Health 16.2 (2014): 77. 
  22. Andersen KG., et al. “The proximal origin of SARS-CoV-2”. Nature Medicine (2020). 
  23. Guan WJ., et al. “Clinical Characteristics of Coronavirus Disease 2019 in China external icon”. The New England Journal of Medicine (2020).
  24. Ruan Q., et al. “Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China”. Intensive Care Medicine 46.5 (2020): 846-848. 
  25. Al‐Bari. “Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases”. Pharmaceutical Research 5.1 (2017): e00293. 
  26. Christian A Devaux., et al. “New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?” International Journal of Antimicrobial Agents 12 (2020):105938. 
  27. Vincent MJ., et al. “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread”. Virology Journal 2.69 (2005). 
  28. Bin Cao MD., et al. “A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19”. The New England Journal of Medicine (2020).
  29. Peiris JS., et al. “HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study”. Lancet 361.9371 (2003): 1767-1772.
  30. Yang Liu., et al. “Viral dynamics in mild and severe cases of Covid-19” . The Lancet Infectious Diseases (2020): 30232-30232. 
  31. Mehta P., et al. “HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression”. Lancet 395.10229 (2020): 1033-1034. 
  32. Gautret P., et al. “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”. International Journal of Antimicrobial Agents (2020): 105949. 
  33. Wang M., et al. “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) In vitro”. Cell Research 30 (2020): 269-271. 
  34. A Trial of Remdesivir in Adults with Mild and Moderate COVID-19.
  35. Covid-19: démarrage de l’essai clinique Coviplasm visant à tester l’efficacité de la transfusion de plasma de patients convalescents du Covid-19 dans le traitement de la maladie.
  36. Li G and De Clercq E. “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. Nature Reviews Drug Discovery 19.3 (2020): 149-150. 
  37. Ren Z., et al. “The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease”. Protein Cell 4 (2013): 248-250. 
  38. Zhang L., et al. “Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors”. Science (2020): eabb3405. 
Citation: Drago Jelovac., et al. “Covid-19 Public Health Emergency: Mini Review and Impact on Maxillofacial Practice in Serbia- What we have Learnt duringOur Wireless Journal Club between 10th and 30th March”. EC Dental Science 19.6 (2020): 56-62.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 21, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk